Cancer and Alzheimer's disease are two of the most feared diagnoses in medicine, but they rarely strike the same person.

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

THC plus a common anti-inflammatory drug show promise.

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

What began as a surprising experiment with cell phone-like signals has led to a promising new approach to treating Alzheimer’s disease. Follow the decades-long research journey behind a head cap ...

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

In 2021, the fda approved a treatment that claims to stop Alzheimer's at the source, removing the plaques in the brain long ...

Three bills would bring Massachusetts back up to speed with constituents’ needs and the innovation of other states.

A common respiratory infection appears in brains with Alzheimer's disease, reopening the debate about the origin of the disease.